Citadel Advisors’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,500
Closed -$123K 14034
2025
Q2
$123K Sell
17,500
-38,200
-69% -$187K ﹤0.01% 11140
2025
Q1
$256K Sell
55,700
-23,300
-29% -$118K ﹤0.01% 9935
2024
Q4
$495K Buy
+79,000
New +$607K ﹤0.01% 8573
2024
Q3
Sell
-300
Closed -$4.79K 15195
2024
Q2
$4.79K Sell
300
-1,500
-83% -$24K ﹤0.01% 13457
2024
Q1
$33.2K Buy
1,800
+500
+38% +$8.88K ﹤0.01% 12597
2023
Q4
$25.4K Buy
1,300
+800
+160% +$13.9K ﹤0.01% 12407
2023
Q3
$10K Buy
+500
New +$10.1K ﹤0.01% 13096
2023
Q2
Sell
-400
Closed -$7.48K 15189
2023
Q1
$7.48K Sell
400
-700
-64% -$15K ﹤0.01% 13718
2022
Q4
$23.7K Buy
+1,100
New +$23.5K ﹤0.01% 13001
2021
Q3
Sell
-17,800
Closed -$525K 14606
2021
Q2
$525K Buy
17,800
+6,800
+62% +$215K ﹤0.01% 9956
2021
Q1
$350K Buy
+11,000
New +$347K ﹤0.01% 10490

Other funds holding SRI

Citadel Advisors's SRI Position: Q1 2026 in Review

Citadel Advisors reduced its Stoneridge (SRI) stake by 67% in Q1 2026, selling an estimated $859K and leaving 60,794 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #10515.

Citadel Advisors first reported a position in SRI in Q1 2014 and has held it in 42 quarters since. The position peaked at $4.86M in Q1 2023. 114 funds tracked by Wall St. Rank hold SRI as of Q1 2026.

  • Citadel Advisors held 60,794 shares of Stoneridge worth $294K as of Q1 2026.
  • Citadel Advisors sold 125,301 Stoneridge shares in Q1 2026, an estimated $859K.
  • Stoneridge made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10515 holding.
  • Citadel Advisors first reported a position in Stoneridge in Q1 2014 and has held it in 42 quarters since.
  • Citadel Advisors's Stoneridge position peaked at $4.86M in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Stoneridge as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.